Mood and cognitive side effects of interferon-alpha therapy

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Interferon-alpha (IFN-alpha) therapy, while effective, can lead to significant central nervous system (CNS) side effects.
• These neurotoxic effects include depression and cognitive changes, potentially compromising treatment efficacy.
• The term 'depression' encompasses a spectrum from sadness to a defined neuropsychiatric disorder.

Purpose of the Study:

• To describe the spectrum of CNS side effects associated with IFN-alpha therapy.
• To identify risk factors and potential etiologies for IFN-alpha neurotoxicity.
• To explore possible interventions for managing these adverse effects.

Main Methods:

• Review of clinical observations and existing research on IFN-alpha neurotoxicity.
• Analysis of the relationship between IFN-alpha's mechanism of action and observed neuropsychiatric symptoms.
• Exploration of potential pharmacologic interventions.

Main Results:

• A syndrome of mood disturbance, memory impairment, and cognitive deficits, resembling mild subcortical dementia, is common with IFN-alpha.
• Risk factors include treatment duration, high dosage, prior cranial irradiation, and pre-existing psychiatric conditions.
• Neuroendocrine and neurochemical alterations associated with major depression subtypes may offer insights into IFN-alpha neurotoxicity.

Conclusions:

• Neuropsychiatric assessment should be a standard part of IFN-alpha therapy care.
• Pharmacologic interventions such as antidepressants, psychostimulants, and opioid antagonists may help mitigate IFN-alpha neurotoxicity.
• Effective palliation of IFN-alpha toxicity is achievable with appropriate management strategies.